Physicians iTrack™ Molteno3®

Overview AlphaRET

Investors ASX Announcements Presentations Share Registry Board of Directors Corporate Governance

News

Clinical Update: 2RT^® Improves Retinal Function in Cases of Intermediate AMD

Media Release AlphaRET

16 Nov, 2020

Nova Eye Medical Establishes "AlphaRET" to Fulfil the Commercial Development of 2RT^®

Media Release AlphaRET

26 Oct, 2020

View ASX Announcements

For media enquires please contact:

Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More